Eli Lilly and Boehringer Ingelheim’s Synjardy XR diabetes combination drug has been approved in the US, giving patients a convenient way of taking two complementary medicines in one tablet.
Eli Lilly and Boehringer Ingelheim’s Jardiance (empagliflozin) and related product Synjardy (empagliflozin and metformin) have been cleared by the FDA for use in children aged 10 years and over ...